Titre : Extrême-Orient

Extrême-Orient : Questions médicales fréquentes

Termes MeSH sélectionnés :

Developing Countries
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Extrême-Orient : Questions médicales les plus fréquentes", "headline": "Extrême-Orient : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Extrême-Orient : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-06", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Extrême-Orient" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Asie", "url": "https://questionsmedicales.fr/mesh/D001208", "about": { "@type": "MedicalCondition", "name": "Asie", "code": { "@type": "MedicalCode", "code": "D001208", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chine", "alternateName": "China", "url": "https://questionsmedicales.fr/mesh/D002681", "about": { "@type": "MedicalCondition", "name": "Chine", "code": { "@type": "MedicalCode", "code": "D002681", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.164" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hong Kong", "alternateName": "Hong Kong", "url": "https://questionsmedicales.fr/mesh/D006723", "about": { "@type": "MedicalCondition", "name": "Hong Kong", "code": { "@type": "MedicalCode", "code": "D006723", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.164.450" } } }, { "@type": "MedicalWebPage", "name": "Tibet", "alternateName": "Tibet", "url": "https://questionsmedicales.fr/mesh/D018609", "about": { "@type": "MedicalCondition", "name": "Tibet", "code": { "@type": "MedicalCode", "code": "D018609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.164.900" } } } ] }, { "@type": "MedicalWebPage", "name": "République démocratique populaire de Corée", "alternateName": "Democratic People's Republic of Korea", "url": "https://questionsmedicales.fr/mesh/D056911", "about": { "@type": "MedicalCondition", "name": "République démocratique populaire de Corée", "code": { "@type": "MedicalCode", "code": "D056911", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.557.500" } } }, { "@type": "MedicalWebPage", "name": "République de Corée", "alternateName": "Republic of Korea", "url": "https://questionsmedicales.fr/mesh/D056910", "about": { "@type": "MedicalCondition", "name": "République de Corée", "code": { "@type": "MedicalCode", "code": "D056910", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.557.750" } } }, { "@type": "MedicalWebPage", "name": "Mongolie", "alternateName": "Mongolia", "url": "https://questionsmedicales.fr/mesh/D008986", "about": { "@type": "MedicalCondition", "name": "Mongolie", "code": { "@type": "MedicalCode", "code": "D008986", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.474.651" } } } ], "about": { "@type": "MedicalCondition", "name": "Extrême-Orient", "alternateName": "Asia, Eastern", "code": { "@type": "MedicalCode", "code": "D005202", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Masoud Dara", "url": "https://questionsmedicales.fr/author/Masoud%20Dara", "affiliation": { "@type": "Organization", "name": "WHO Regional Office for Europe, Copenhagen, Denmark. Electronic address: daram@who.int." } }, { "@type": "Person", "name": "Yakubu Egigogo Raji", "url": "https://questionsmedicales.fr/author/Yakubu%20Egigogo%20Raji", "affiliation": { "@type": "Organization", "name": "Department of Medical Microbiology Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "European Board and College of Obstetrics and Gynaecology (EBCOG), European Society of Contraception and Reproductive Health (ESCRH)." } }, { "@type": "Person", "name": "Tzung-Dau Wang", "url": "https://questionsmedicales.fr/author/Tzung-Dau%20Wang", "affiliation": { "@type": "Organization", "name": "Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan." } }, { "@type": "Person", "name": "Kazuomi Kario", "url": "https://questionsmedicales.fr/author/Kazuomi%20Kario", "affiliation": { "@type": "Organization", "name": "Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Economic freedom, inclusive growth, and financial development: A heterogeneous panel analysis of developing countries.", "datePublished": "2023-07-11", "url": "https://questionsmedicales.fr/article/37432915", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0288346" } }, { "@type": "ScholarlyArticle", "name": "Ensuring environmental inclusion in developing countries: the role of macroeconomic policies.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36474034", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-022-24596-z" } }, { "@type": "ScholarlyArticle", "name": "Evaluating the quality of health technology assessment reports in a developing country.", "datePublished": "2023-07-31", "url": "https://questionsmedicales.fr/article/37553743", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.26719/emhj.22.017" } }, { "@type": "ScholarlyArticle", "name": "Investigating the impact of air pollution in selected African developing countries.", "datePublished": "2023-04-17", "url": "https://questionsmedicales.fr/article/37067712", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-023-26998-z" } }, { "@type": "ScholarlyArticle", "name": "The national health program for vitamin D supplementation in a developing country.", "datePublished": "2023-01-20", "url": "https://questionsmedicales.fr/article/36963898", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clnesp.2023.01.012" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Asie", "item": "https://questionsmedicales.fr/mesh/D001208" }, { "@type": "ListItem", "position": 4, "name": "Extrême-Orient", "item": "https://questionsmedicales.fr/mesh/D005202" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Extrême-Orient - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Extrême-Orient", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Extrême-Orient", "description": "Comment diagnostiquer une infection parasitaire en Extrême-Orient ?\nQuels examens pour le cancer du foie en Asie ?\nComment identifier une tuberculose en Extrême-Orient ?\nQuels tests pour le paludisme en Asie ?\nComment diagnostiquer une hépatite virale ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Developing+Countries&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Extrême-Orient", "description": "Quels sont les symptômes du choléra ?\nQuels signes d'une infection par le virus Nipah ?\nQuels symptômes de la dengue ?\nQuels symptômes de la grippe aviaire ?\nQuels signes d'une infection à Hantavirus ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Developing+Countries&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Extrême-Orient", "description": "Comment prévenir le choléra ?\nQuelles mesures pour éviter la dengue ?\nComment prévenir la tuberculose ?\nQuelles précautions pour le paludisme ?\nComment éviter l'hépatite A ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Developing+Countries&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Extrême-Orient", "description": "Quel traitement pour la tuberculose ?\nComment traiter le paludisme ?\nQuel traitement pour l'hépatite B ?\nComment traiter la dengue ?\nQuel traitement pour le choléra ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Developing+Countries&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Extrême-Orient", "description": "Quelles complications du choléra ?\nQuelles complications de la dengue ?\nQuelles complications de l'hépatite B ?\nQuelles complications de la tuberculose ?\nQuelles complications du paludisme ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Developing+Countries&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Extrême-Orient", "description": "Quels sont les facteurs de risque du choléra ?\nQuels facteurs de risque pour la dengue ?\nQuels facteurs de risque pour l'hépatite A ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour le paludisme ?", "url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=Developing+Countries&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection parasitaire en Extrême-Orient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur des tests sanguins, des analyses de selles et des antécédents de voyage." } }, { "@type": "Question", "name": "Quels examens pour le cancer du foie en Asie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie, la tomodensitométrie et les tests de marqueurs tumoraux sont utilisés." } }, { "@type": "Question", "name": "Comment identifier une tuberculose en Extrême-Orient ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un test cutané, une radiographie pulmonaire et des cultures de crachats sont nécessaires." } }, { "@type": "Question", "name": "Quels tests pour le paludisme en Asie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins spécifiques, comme le frottis sanguin, sont utilisés pour le diagnostic." } }, { "@type": "Question", "name": "Comment diagnostiquer une hépatite virale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins pour détecter les anticorps et les antigènes sont effectués." } }, { "@type": "Question", "name": "Quels sont les symptômes du choléra ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent diarrhée aqueuse, vomissements et déshydratation rapide." } }, { "@type": "Question", "name": "Quels signes d'une infection par le virus Nipah ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, maux de tête, confusion et troubles respiratoires sont fréquents." } }, { "@type": "Question", "name": "Quels symptômes de la dengue ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs articulaires, éruptions cutanées et saignements peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes de la grippe aviaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, toux, difficultés respiratoires et douleurs musculaires sont typiques." } }, { "@type": "Question", "name": "Quels signes d'une infection à Hantavirus ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs abdominales, et symptômes respiratoires peuvent se manifester." } }, { "@type": "Question", "name": "Comment prévenir le choléra ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'accès à l'eau potable, l'hygiène et la vaccination sont cruciaux." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la dengue ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques sont efficaces." } }, { "@type": "Question", "name": "Comment prévenir la tuberculose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination BCG et le dépistage précoce des cas sont recommandés." } }, { "@type": "Question", "name": "Quelles précautions pour le paludisme ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des moustiquaires et des médicaments prophylactiques lors de voyages à risque." } }, { "@type": "Question", "name": "Comment éviter l'hépatite A ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains, consommer de l'eau potable et se faire vacciner sont essentiels." } }, { "@type": "Question", "name": "Quel traitement pour la tuberculose ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement standard inclut des antibiotiques sur plusieurs mois, comme l'isoniazide." } }, { "@type": "Question", "name": "Comment traiter le paludisme ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments antipaludiques comme la chloroquine ou l'artémisinine sont prescrits." } }, { "@type": "Question", "name": "Quel traitement pour l'hépatite B ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux comme le ténofovir et l'entécavir sont souvent utilisés." } }, { "@type": "Question", "name": "Comment traiter la dengue ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement spécifique ; la réhydratation et le soulagement des symptômes sont essentiels." } }, { "@type": "Question", "name": "Quel traitement pour le choléra ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La réhydratation orale ou intraveineuse et les antibiotiques sont essentiels." } }, { "@type": "Question", "name": "Quelles complications du choléra ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation sévère et le choc hypovolémique peuvent être mortels." } }, { "@type": "Question", "name": "Quelles complications de la dengue ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Le syndrome de choc dengue et les hémorragies peuvent survenir dans les cas graves." } }, { "@type": "Question", "name": "Quelles complications de l'hépatite B ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La cirrhose et le cancer du foie sont des complications possibles à long terme." } }, { "@type": "Question", "name": "Quelles complications de la tuberculose ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la fibrose pulmonaire et la dissémination à d'autres organes." } }, { "@type": "Question", "name": "Quelles complications du paludisme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "L'anémie sévère, l'insuffisance rénale et le coma peuvent survenir dans les cas graves." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du choléra ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'accès limité à l'eau potable et une mauvaise hygiène augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la dengue ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones tropicales et avoir des moustiques à proximité sont des risques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour l'hépatite A ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Voyager dans des régions à risque et consommer des aliments contaminés augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la tuberculose ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "La malnutrition, le VIH et le surpeuplement sont des facteurs de risque majeurs." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le paludisme ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Vivre ou voyager dans des zones endémiques et ne pas utiliser de protection contre les moustiques." } } ] } ] }

Sources (10000 au total)

Evaluating the quality of health technology assessment reports in a developing country.

No single method of health technology assessment (HTA) can meet all the policy- and decision-making needs in a country. However, there should be minimum criteria for performing HTA worldwide, and many... This study aimed to assess the quality of HTA reports in the Islamic Republic of Iran.... We examined all the HTA research reports published by the Iranian HTA office up to 2020, using the International Network of Agencies for Health Technology Assessment checklist for quality assessment.... A total of 97 reports were examined, of which only 10.0% provided complete and appropriate contact details for further information and 5.6% clearly stated a conflict of interest. In 87.78% of the repo... We recommend that minimum standards be established for the HTA process so that healthcare policy- and decision-makers can make reliable decisions on the basis of the HTA reports....

The national health program for vitamin D supplementation in a developing country.

Previous studies have reported a high frequency of vitamin D deficiency (VDD) among different age groups in Iran.... In this study, the current coverage, status of vitamin D supplement taking, and program efficacy have been evaluated by the Office of Nutrition Department Society in Iran since 2014.... This study was conducted in collaboration with the International UNESCO center for Health-Related Basic Sciences and Human Nutrition and the Office of Nutrition Department Society. Sixty three medical... Quantitative analysis showed that availability coverage was 74.96% and 77.56% and accessibility was 80.70% and 83.26% in elderly and middle-aged subjects, respectively in 2018. The acceptability was a... The frequency of taking vitamin D supplements was 27.0% in Iran in 2018. The frequency of taking of vitamin D supplements among vitamin D deficient group (serum vitamin D levels <19.99 ng/ml) was 43.6...

Outcomes of burns patients in a developing country: A single centre's experience.

Pelonomi Tertiary Hospital is the only hospital in the Free State Province with a burns unit. We do not have official data to assess our performance in the management of burns.... To determine the Lethal Area 50 (LA50) index for the Pelonomi Tertiary Hospital's burns unit. Furthermore, to determine the morbidity that affects burns patients at the institution, and the factors as... We used Redcap to capture demographic and clinical data of burn patients admitted to our institution between January 2014 and December 2018. Logistic regression was used to determine significant predi... Our study had a male preponderance, with 59.7% (601) male, 39.9% (401) female and 0.4% (4) missing sex. We had a mean age of 19.4 years, of which 53.38% (n=537) were paediatric patients and 46.32% (n=... The epidemiology of burn patients and working conditions at Pelonomi Tertiary Hospital are similar to other burn units in the country; however, our mortality rate is higher than at most centres. The L...

Technical aspects of inguino scrotal hernia surgery in developing countries.

Technical aspects of inguinoscrotal herniorrhaphy performed in low to middle income countries (LMICs) are described here to help surgeons who will operate on these challenging hernias in austere setti... Technical considerations related to operative repair were delineated with the consensus of 7 surgeons with extensive experience in inguinoscrotal hernia repair in LMICs. Important steps and illustrati... The authors have cumulatively performed over 1775 inguinoscrotal Lichtenstein operations in LMICs. While dedicated, reliable, long-term follow-up is unavailable from LMICs, one author reports outcomes... There is a difference between inguinal hernias found in LMICs and those seen in high-income countries with larger, chronic, and more technically challenging pathology. The consequences of intra-operat...